propranolol has been researched along with Insulin Sensitivity in 60 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Excerpt | Relevance | Reference |
---|---|---|
"At present, beta-adrenergic blockade with propranolol represents probably the most efficacious anticatabolic therapy in the treatment of burns." | 8.87 | Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? ( Gauglitz, GG; Herndon, DN; Jeschke, MG; Williams, FN, 2011) |
" The current study was undertaken to investigate whether sympathetic nervous system and l-arginine-nitric oxide pathway activities are linked to insulin resistance in rats under chronic low salt intake." | 7.73 | Insulin resistance due to chronic salt restriction is corrected by alpha and beta blockade and by L-arginine. ( Catanozi, S; do Nascimento, CA; Dolnikoff, MS; Furukawa, LN; Heimann, JC; Leandro, SM; Quintão, EC; Rocha, JC; Ruivo, GF, 2006) |
"Sixty-eight determination of in vivo insulin resistance were conducted in 35 males (aged 29-63 yr) by measurement of steady-state plasma glucose levels during a combined intravenous infusion of propranolol, epinephrine, glucose, and insulin." | 7.66 | Cardiac arrhythmias during epinephrine-propranolol infusions for measurement of in vivo insulin resistance. ( Bassett, DR; Lampman, RM; Santinga, JT; Savage, PJ, 1981) |
"Insulin resistance was induced by HFrHFD feeding for 16 weeks." | 5.62 | Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance β-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin. ( Ahmed, HMS; Ibrahim, IAAE; Ibrahim, WS; Mahmoud, AAA; Mahmoud, MF, 2021) |
"Propranolol is a β-adrenergic antagonist commonly used in the treatment of hypertension or acute anxiety." | 5.39 | Propranolol reduces cognitive deficits, amyloid β levels, tau phosphorylation and insulin resistance in response to chronic corticosterone administration. ( Aguirre, N; Dobarro, M; Orejana, L; Ramírez, MJ, 2013) |
"Treatment with propranolol did not alter serum insulin levels, area-under-the-curve glucose, or KITT values." | 5.34 | Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. ( Bhatt, P; Goyal, R; Makwana, D; Santani, D, 2007) |
"At present, beta-adrenergic blockade with propranolol represents probably the most efficacious anticatabolic therapy in the treatment of burns." | 4.87 | Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs? ( Gauglitz, GG; Herndon, DN; Jeschke, MG; Williams, FN, 2011) |
" The current study was undertaken to investigate whether sympathetic nervous system and l-arginine-nitric oxide pathway activities are linked to insulin resistance in rats under chronic low salt intake." | 3.73 | Insulin resistance due to chronic salt restriction is corrected by alpha and beta blockade and by L-arginine. ( Catanozi, S; do Nascimento, CA; Dolnikoff, MS; Furukawa, LN; Heimann, JC; Leandro, SM; Quintão, EC; Rocha, JC; Ruivo, GF, 2006) |
" To test the role of the adrenergic system, alpha- and beta-adrenergic receptor antagonists, phentolamine and propranolol, were tested for the ability to block HDIR produced by hemorrhage." | 3.73 | Hemorrhage results in hepatic insulin-sensitizing substance-dependent insulin resistance mediated by somatostatin in rats. ( Lautt, WW; Seredycz, LI, 2006) |
" We describe a 72-year-old lady who initially presented with episodic hypoglycemia secondary to an insulinoma that was controlled by diazoxide." | 3.69 | Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms. ( Alberti, KG; Kendall-Taylor, P; Trajano, LR; Walker, M, 1994) |
" Administration of the beta-adrenergic agonist isoproterenol during the period of insulin resistance (days 26-40 after primary immunization), largely restored fat cell responsiveness to insulin, and eliminated the appearance of fasting hyperglycemia." | 3.67 | Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists. ( Cohen, IR; Elias, D; Rapoport, M; Shechter, Y, 1988) |
"Sixty-eight determination of in vivo insulin resistance were conducted in 35 males (aged 29-63 yr) by measurement of steady-state plasma glucose levels during a combined intravenous infusion of propranolol, epinephrine, glucose, and insulin." | 3.66 | Cardiac arrhythmias during epinephrine-propranolol infusions for measurement of in vivo insulin resistance. ( Bassett, DR; Lampman, RM; Santinga, JT; Savage, PJ, 1981) |
"In six patients with chemical diabetes, insulin resistance was assessed by the steady-state plasma glucose (SSPG) level during a constant infusion of epinephrine, propranolol, glucose and insulin." | 3.66 | Insulin resistance and carbohydrate oxidation in patients with chemical diabetes. ( Chevaux, F; Curchod, B; Felber, JP; Jéquier, E, 1982) |
" These five groups were then compared on the basis of their insulin response during the oral glucose tolerance test and on the ability of exogenously infused insulin to limit hyperglycemia during a continuous infusion of glucose and insulin, while endogenous insulin was inhibited by the infusion of epinephrine and propranolol." | 3.65 | Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? ( Bernstein, R; Davis, B; Olefsky, JM; Reaven, GM, 1976) |
"The insulin resistance was due to an attenuated insulin effect on both inhibition of Ra (impaired by 37%) and stimulation of Rd (impaired by 61%)." | 2.66 | Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation. ( Attvall, S; Eriksson, BM; Fowelin, J; Lager, I; Smith, U; von Schenck, H, 1987) |
"The insulin resistance was prevented by infusing propranolol (clamp I 2." | 2.66 | Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation. ( Attvall, S; Fowelin, J; Lager, I; Smith, U; von Schenck, H, 1987) |
"Insulin resistance was induced by HFrHFD feeding for 16 weeks." | 1.62 | Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance β-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin. ( Ahmed, HMS; Ibrahim, IAAE; Ibrahim, WS; Mahmoud, AAA; Mahmoud, MF, 2021) |
"Obesity-associated hypertension is accompanied by a number of cardiovascular risk factors including vascular insulin resistance (IR) and higher sympathetic nervous activity." | 1.46 | Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice. ( Brum, PC; Carneiro, EM; da Silva Franco, N; Davel, AP; Guizoni, DM; Lubaczeuski, C; Santos-Silva, JC; Victorio, JA, 2017) |
" Cumulative dose-response curves with isoproterenol were established in basal condition, and after fifteen minutes of pre-incubation with propranolol (1x10-6 M)." | 1.46 | Inotropic and chronotropic effects of propranolol in isolated atrium of rats with fructose-induced insulin-resistance ( Mago, N; Rodríguez, G, 2017) |
"Insulin resistance is a condition in which cells are defective in response to the actions of insulin in tissue glucose uptake." | 1.43 | Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner. ( Denkaew, T; Mangmool, S; Nishida, M; Parichatikanond, W; Phosri, S; Pinthong, D; Shimauchi, T, 2016) |
"Rats with cerebral ischemia developed higher blood glucose, and insulin levels, and insulin resistance index, as well as hepatic gluconeogenic enzyme expression compared with the sham-treated group." | 1.40 | Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats. ( Chen, CJ; Chuang, YH; Lin, SY; Sheu, WH; Tung, KC; Wang, YY, 2014) |
"Donohue syndrome (leprechaunism; OMIM *246200) is a rare, recessively inherited disorder of extreme insulin resistance due to mutations in the insulin receptor gene (INSR) causing either defects in insulin binding or receptor autophosphorylation and tyrosine kinase activity." | 1.39 | Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation. ( Battelino, T; Bratanič, N; Bratina, N; Hovnik, T; Kovač, J; Paro, D; Podkrajšek, KT; Podnar, T, 2013) |
"Propranolol is a β-adrenergic antagonist commonly used in the treatment of hypertension or acute anxiety." | 1.39 | Propranolol reduces cognitive deficits, amyloid β levels, tau phosphorylation and insulin resistance in response to chronic corticosterone administration. ( Aguirre, N; Dobarro, M; Orejana, L; Ramírez, MJ, 2013) |
"We report one such case patient who had delayed puberty and portal hypertension as unique features amongst the characteristic phenotypes of this syndrome." | 1.38 | An unusual cause of delayed puberty: Berardinelli- Seip syndrome. ( Dhull, P; Kumar, KV; Patnaik, SK; Upreti, V, 2012) |
"Treatment with propranolol did not alter serum insulin levels, area-under-the-curve glucose, or KITT values." | 1.34 | Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. ( Bhatt, P; Goyal, R; Makwana, D; Santani, D, 2007) |
"Propranolol was also able to ameliorate the hepatic insulin resistance produced by TNF." | 1.29 | Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor. ( Lang, CH, 1993) |
" Dose-response curves for phentolamine and propranolol established maximally effective doses (3." | 1.28 | Influence of sympatho-adrenal system on insulin sensitivity using the euglycemic clamp technique. ( Funado, T; Iguchi, A; Iida, T; Kato, K; Kusunoki, M; Oshida, Y; Sakamoto, N; Sato, Y; Suga, T, 1992) |
"DESIGN - Endotoxin shock was obtained in dogs by giving S Typhimurium endotoxin intravenously (1 mg." | 1.28 | Insulin and beta adrenergic effects during endotoxin shock: in vivo myocardial interactions. ( Law, WR; McLane, MP; Raymond, RM, 1990) |
"Thus, hypoglycemia is followed by prolonged (6- to 8-h) insulin resistance." | 1.28 | Combined effect of growth hormone and cortisol on late posthypoglycemic insulin resistance in humans. ( Attvall, S; Fowelin, J; Lager, I; Smith, U; Von Schenck, H, 1989) |
"Insulin resistance was quantified with two different methods in 30 subjects with varying degrees of glucose tolerance." | 1.26 | Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. ( Doberne, L; Greenfield, MS; Kraemer, F; Reaven, G; Tobey, T, 1981) |
" Consequently, the insulin dose-response curve of SSBG apparently shifted rightwards in KK mice." | 1.26 | Determination of overall insulin sensitivity in diabetic mice, KK. ( Ikeda, H; Ishikawa, E; Iwatsuka, H; Taketomi, S, 1982) |
"Insulin resistance was estimated by measuring the steady-state plasma glucose response to a continuous infusion of insulin, glucose, epinephrine, and propranolol." | 1.26 | Aging and insulin resistance in a group of nonobese male volunteers. ( Javorski, WC; Kimmerling, G; Reaven, GM, 1977) |
"Insulin resistance was estimated by measuring the steady-state plasma glucose response to a continuous infusion of insulin, glucose, epinephrine, and propranolol." | 1.26 | Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus. ( Javorski, C; Kimmerling, G; Olefsky, JM; Reaven, GM, 1976) |
"Insulin resistance was estimated in nine subjects with impaired glucose tolerance (IGT) and eleven healthy, age and body-weight matched controls." | 1.26 | Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance. ( Ratzmann, KP; Schulz, B; Witt, S, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (53.33) | 18.7374 |
1990's | 10 (16.67) | 18.2507 |
2000's | 6 (10.00) | 29.6817 |
2010's | 11 (18.33) | 24.3611 |
2020's | 1 (1.67) | 2.80 |
Authors | Studies |
---|---|
Ibrahim, WS | 1 |
Ahmed, HMS | 1 |
Mahmoud, AAA | 1 |
Mahmoud, MF | 1 |
Ibrahim, IAAE | 1 |
da Silva Franco, N | 1 |
Lubaczeuski, C | 1 |
Guizoni, DM | 1 |
Victorio, JA | 1 |
Santos-Silva, JC | 1 |
Brum, PC | 1 |
Carneiro, EM | 1 |
Davel, AP | 1 |
Rodríguez, G | 1 |
Mago, N | 1 |
Upreti, V | 1 |
Dhull, P | 1 |
Patnaik, SK | 1 |
Kumar, KV | 1 |
Abe, Y | 1 |
Watanabe, T | 1 |
Wang, YY | 1 |
Lin, SY | 1 |
Chuang, YH | 1 |
Sheu, WH | 1 |
Tung, KC | 1 |
Chen, CJ | 1 |
Blagosklonny, MV | 1 |
Mangmool, S | 1 |
Denkaew, T | 1 |
Phosri, S | 1 |
Pinthong, D | 1 |
Parichatikanond, W | 1 |
Shimauchi, T | 1 |
Nishida, M | 1 |
Gauglitz, GG | 1 |
Williams, FN | 1 |
Herndon, DN | 1 |
Jeschke, MG | 1 |
Erice, E | 1 |
Llop, E | 1 |
Berzigotti, A | 1 |
Abraldes, JG | 1 |
Conget, I | 1 |
Seijo, S | 1 |
Reverter, E | 1 |
Albillos, A | 1 |
Bosch, J | 1 |
García-Pagán, JC | 1 |
Dobarro, M | 1 |
Orejana, L | 1 |
Aguirre, N | 1 |
Ramírez, MJ | 1 |
Hovnik, T | 1 |
Bratanič, N | 1 |
Podkrajšek, KT | 1 |
Kovač, J | 1 |
Paro, D | 1 |
Podnar, T | 1 |
Bratina, N | 1 |
Battelino, T | 1 |
Fasshauer, M | 1 |
Klein, J | 1 |
Lossner, U | 1 |
Paschke, R | 1 |
Tamaya-Mori, N | 1 |
Uemura, K | 1 |
Tanaka, S | 1 |
Iguchi, A | 2 |
Ruivo, GF | 1 |
Leandro, SM | 1 |
do Nascimento, CA | 1 |
Catanozi, S | 1 |
Rocha, JC | 1 |
Furukawa, LN | 1 |
Dolnikoff, MS | 1 |
Quintão, EC | 1 |
Heimann, JC | 1 |
Seredycz, LI | 1 |
Lautt, WW | 1 |
Bhatt, P | 1 |
Makwana, D | 1 |
Santani, D | 1 |
Goyal, R | 1 |
Hsieh, PS | 1 |
Hong, LZ | 1 |
Gray, RS | 1 |
Borsey, DQ | 1 |
Irvine, WJ | 1 |
Duncan, LJ | 1 |
Clarke, BF | 1 |
Narimiya, M | 1 |
Azhar, S | 1 |
Dolkas, CB | 1 |
Mondon, CE | 1 |
Sims, C | 1 |
Wright, DW | 1 |
Reaven, GM | 11 |
Schäfer, H | 1 |
Ratzmann, KP | 1 |
Witt, S | 1 |
Schulz, B | 1 |
Dieterlen, P | 1 |
Desjeux, JF | 1 |
Giraud, M | 1 |
Villard, S | 1 |
Lestradet, H | 1 |
Greenfield, MS | 1 |
Doberne, L | 1 |
Kraemer, F | 1 |
Tobey, T | 1 |
Reaven, G | 2 |
Fujimoto, K | 1 |
Sakaguchi, T | 1 |
Ui, M | 1 |
Taketomi, S | 1 |
Ikeda, H | 1 |
Ishikawa, E | 1 |
Iwatsuka, H | 1 |
Chevaux, F | 1 |
Curchod, B | 1 |
Felber, JP | 1 |
Jéquier, E | 1 |
Lampman, RM | 1 |
Santinga, JT | 1 |
Bassett, DR | 1 |
Savage, PJ | 1 |
Walker, M | 1 |
Trajano, LR | 1 |
Alberti, KG | 1 |
Kendall-Taylor, P | 1 |
Lang, CH | 2 |
Virkamäki, A | 1 |
Yki-Järvinen, H | 1 |
Niklasson, M | 1 |
Holmäng, A | 1 |
Lönnroth, P | 1 |
Berger, JJ | 1 |
Barnard, RJ | 1 |
Bernstein, R | 1 |
Davis, B | 1 |
Olefsky, JM | 6 |
Kimmerling, G | 3 |
Javorski, WC | 1 |
Javorski, C | 1 |
Ginsberg, H | 2 |
Olefsky, J | 2 |
Crapo, PA | 1 |
Kusunoki, M | 1 |
Oshida, Y | 1 |
Iida, T | 1 |
Suga, T | 1 |
Funado, T | 1 |
Sato, Y | 1 |
Kato, K | 1 |
Sakamoto, N | 1 |
Foss, A | 1 |
Ahrén, B | 1 |
Lithell, HO | 1 |
Law, WR | 1 |
McLane, MP | 1 |
Raymond, RM | 1 |
Boström, M | 1 |
Nie, Z | 1 |
Goertz, G | 1 |
Henriksson, J | 1 |
Wallberg-Henriksson, H | 1 |
Fowelin, J | 3 |
Attvall, S | 3 |
Von Schenck, H | 3 |
Smith, U | 3 |
Lager, I | 3 |
Bosquet, F | 1 |
Grimaldi, A | 1 |
Eriksson, BM | 1 |
Elias, D | 1 |
Rapoport, M | 1 |
Cohen, IR | 1 |
Shechter, Y | 1 |
Ravussin, E | 1 |
Bogardus, C | 1 |
Schwartz, RS | 1 |
Robbins, DC | 1 |
Wolfe, RR | 1 |
Horton, ES | 1 |
Danforth, E | 1 |
Sims, EA | 1 |
Farquhar, JW | 2 |
West, RJ | 1 |
Fosbrooke, AS | 1 |
Lloyd, JK | 1 |
Swenson, RS | 1 |
Peterson, DT | 1 |
Eshleman, M | 1 |
Boucher, BJ | 1 |
Cohen, RD | 1 |
Frankel, RJ | 1 |
Mason, AS | 1 |
Broadley, G | 1 |
Abramson, EA | 1 |
Arky, RA | 1 |
5 reviews available for propranolol and Insulin Sensitivity
Article | Year |
---|---|
Koschei the immortal and anti-aging drugs.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Caloric Restriction; Exercise; Folklore; G | 2014 |
Burns: where are we standing with propranolol, oxandrolone, recombinant human growth hormone, and the new incretin analogs?
Topics: Anabolic Agents; Blood Glucose; Burns; Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin- | 2011 |
Is the basic lesion in diabetes insulin deficiency or insulin resistance?
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Epinephrine; Glucose; Humans; Hyperglycemi | 1976 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; | 1991 |
[Blood glucose counter-regulation].
Topics: Adrenergic beta-Antagonists; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids; Glu | 1985 |
3 trials available for propranolol and Insulin Sensitivity
Article | Year |
---|---|
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; | 1991 |
Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Female; Heart Rate; Humans; Hyperglycemia; Hypoglyc | 1987 |
Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.
Topics: Adult; Female; Glucose; Heart Rate; Humans; Hypoglycemia; Insulin; Insulin Resistance; Male; Propran | 1987 |
53 other studies available for propranolol and Insulin Sensitivity
Article | Year |
---|---|
Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance β-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin.
Topics: Animals; beta-Arrestin 2; Blood Glucose; Diet, High-Fat; Fructose; Glucose; Heart; Insulin; Insulin | 2021 |
Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Diet, High-Fat; Endot | 2017 |
Inotropic and chronotropic effects of propranolol in isolated atrium of rats with fructose-induced insulin-resistance
Topics: Adrenergic beta-Antagonists; Animals; Atrial Function; Fructose; Heart Atria; Heart Rate; In Vitro T | 2017 |
An unusual cause of delayed puberty: Berardinelli- Seip syndrome.
Topics: Administration, Cutaneous; Adolescent; Atorvastatin; Combined Modality Therapy; Diet, Fat-Restricted | 2012 |
Renal tubular dysfunction in patients with molecular defects of the insulin receptor gene.
Topics: Cardiomyopathy, Hypertrophic; Donohue Syndrome; Humans; Insulin Resistance; Insulin-Like Growth Fact | 2014 |
Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats.
Topics: Adipose Tissue; Alanine Transaminase; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocyt | 2014 |
Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cyclic AMP-Dependent Protein Kinases | 2016 |
Insulin resistance in patients with cirrhosis and portal hypertension.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Insulin Resistance; Liver; Liver Ci | 2012 |
Propranolol reduces cognitive deficits, amyloid β levels, tau phosphorylation and insulin resistance in response to chronic corticosterone administration.
Topics: Adrenergic beta-Antagonists; Amyloid beta-Peptides; Animals; Cognition Disorders; Corticosterone; Di | 2013 |
Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.
Topics: Cardiomyopathy, Hypertrophic; Donohue Syndrome; Fatal Outcome; Growth Disorders; Humans; Insulin Res | 2013 |
Isoproterenol is a positive regulator of the suppressor of cytokine signaling-3 gene expression in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adenylyl Cyclases; Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Ani | 2002 |
Aging accelerates dietary lard-induced increase in blood pressure in rats.
Topics: Aging; Animals; Blood Glucose; Dietary Fats; Epinephrine; Glucose; Hypertension; Insulin; Insulin Re | 2003 |
Insulin resistance due to chronic salt restriction is corrected by alpha and beta blockade and by L-arginine.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arginine; Blood Pressure; Diet; | 2006 |
Hemorrhage results in hepatic insulin-sensitizing substance-dependent insulin resistance mediated by somatostatin in rats.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Blood Glucose; Glucose Clamp Technique; Hemorrhage | 2006 |
Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
Topics: Adrenergic beta-Antagonists; Animals; Appetite; Blood Glucose; Blood Pressure; Body Mass Index; Body | 2007 |
Augmentation of nitric oxide is crucial for the time-dependent effects of rosiglitazone on blood pressure and baroreflex function in rats.
Topics: Administration, Oral; Animals; Arteries; Atropine Derivatives; Autonomic Nervous System; Baroreflex; | 2008 |
Non-insulin-treated ICA positive and negative diabetics are equally insulin resistant.
Topics: Adult; Antibodies; Autoantibodies; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type | 1983 |
Insulin resistance in older rats.
Topics: Aging; Animals; Blood Glucose; Body Composition; Epinephrine; Glycogen; Glycogen Synthase; Hindlimb; | 1984 |
Adrenal function and the action of propranolol in surgical stress-mediated insulin resistance of glucose utilization by peripheral tissues in vivo. Inhibition of glucose accumulation in skeletal muscle.
Topics: Adrenal Glands; Adrenalectomy; Animals; Blood Glucose; Extracellular Space; Female; Glucose; Glucose | 1984 |
Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; | 1982 |
[Measurement of insulin sensitivity in obese or diabetic children in vivo. A comparison of three methods (author's transl)].
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Epinephrine; Glucose; Humans; Insuli | 1980 |
Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Epinephrine; Female; Glucose; Humans; Infusions, Parenteral | 1981 |
Adrenergic mechanisms in the hyperglycaemia and hyperinsulinaemia of diabetic KK mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Epinephrine; Insulin; Insulin Resistance; M | 1981 |
Determination of overall insulin sensitivity in diabetic mice, KK.
Topics: 3-O-Methylglucose; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Epinephrine; Glucose; In | 1982 |
Insulin resistance and carbohydrate oxidation in patients with chemical diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Dietary Carbohydrates; Epinephrine; Female; Glucose; Humans | 1982 |
Cardiac arrhythmias during epinephrine-propranolol infusions for measurement of in vivo insulin resistance.
Topics: Adult; Arrhythmias, Cardiac; Blood Glucose; Blood Pressure; Epinephrine; Exercise Test; Heart Rate; | 1981 |
Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Topics: Aged; C-Peptide; Diazoxide; Female; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulinoma; P | 1994 |
Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Glucose; Glucose Clamp Technique; Insulin; Insulin R | 1993 |
Mechanisms of insulin resistance during acute endotoxemia.
Topics: Animals; Blood Glucose; Blood Pressure; Catecholamines; Endotoxins; Glycogen; Glycolysis; Insulin Re | 1994 |
Induction of rat muscle insulin resistance by epinephrine is accompanied by increased interstitial glucose and lactate concentrations.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Cobalt Radioisotopes; Epinephrine; Extracellular Space; | 1998 |
Effect of diet on fat cell size and hormone-sensitive lipase activity.
Topics: Adipocytes; Animals; Cell Size; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Sucrose; Fatty Ac | 1999 |
Insulin resistance and insulin secretion in patients with chemical diabetes: implications concerning the pathogenesis of idiopathic diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus; Epinephrine; Fasting; Glucose Tolerance Test; Humans; Hyperglycemi | 1979 |
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?
Topics: Adult; Diabetes Mellitus; Diabetic Ketoacidosis; Epinephrine; Female; Glucose Tolerance Test; Humans | 1976 |
Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes.
Topics: Blood Glucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistanc | 1977 |
Aging and insulin resistance in a group of nonobese male volunteers.
Topics: Adult; Age Factors; Aged; Blood Glucose; Epinephrine; Glucose Tolerance Test; Humans; Insulin; Insul | 1977 |
Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus.
Topics: Adult; Diabetes Mellitus; Epinephrine; Fasting; Glucose; Glucose Tolerance Test; Homeostasis; Humans | 1976 |
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia.
Topics: Adult; Aged; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Epinephrine; Fasting; Femal | 1975 |
Metabolic effects of increased caloric intake in man.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Diet; Eating; Epinephrine; Fasting; Female; Glucose; | 1975 |
Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism.
Topics: Animals; Atenolol; Deoxyglucose; Escherichia coli Infections; Glucose; Glucose Clamp Technique; Insu | 1992 |
Influence of sympatho-adrenal system on insulin sensitivity using the euglycemic clamp technique.
Topics: Adrenal Medulla; Animals; Dose-Response Relationship, Drug; Epinephrine; Glucose; Glucose Clamp Tech | 1992 |
Insulin secretion and sensitivity after partial hepatectomy in the rat.
Topics: Animals; Blood Glucose; Epinephrine; Glucose; Hepatectomy; Hyperglycemia; Insulin; Insulin Resistanc | 1991 |
Insulin and beta adrenergic effects during endotoxin shock: in vivo myocardial interactions.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Female; Glucose; Insulin; Insulin Resistance; | 1990 |
Indirect effect of catecholamines on development of insulin resistance in skeletal muscle from diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Biological Transport; Blood Glucose; Catecholamines; Diabetes | 1989 |
Combined effect of growth hormone and cortisol on late posthypoglycemic insulin resistance in humans.
Topics: Adult; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Female; Glucose; Humans; Hydrocortiso | 1989 |
Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.
Topics: Adipose Tissue; Aminophylline; Animals; Fasting; Hyperglycemia; Immunoglobulin Idiotypes; Insulin; I | 1988 |
Glucose-induced thermogenesis and insulin resistance in man.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Body Weight; Diabetes Mellitus; Diabetes Melli | 1985 |
Reappraisal of the role of insulin in hypertriglyceridemia.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Diet; Epinephrine; Female; Glucose; Glucose Tolera | 1974 |
Metabolic studies and autonomic function in children with partial lipodystrophy.
Topics: Adipose Tissue; Blood Glucose; Carbohydrate Metabolism; Child; Child, Preschool; Cholesterol; Fatty | 1974 |
Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Epinephrine; Female; Glucose; Glucose Tolerance Test; Human | 1973 |
Effect of acute uremia on various aspects of carbohydrate metabolism in dogs.
Topics: Acute Disease; Animals; Blood Glucose; Carbohydrate Metabolism; Creatinine; Dogs; Epinephrine; Fasti | 1973 |
Partial and total lipodystrophy: changes in circulating sugar, free fatty acids, insulin and growth hormone following the administration of glucose and of insulin.
Topics: Adult; Blood Glucose; Child; Fatty Acids, Nonesterified; Female; Glucose; Glucose Tolerance Test; Gr | 1973 |
Relationship between insulin response during the intravenous glucose tolerance test, rate of fractional glucose removal and the degree of insulin resistance in normal adults.
Topics: Adult; Blood Glucose; Epinephrine; Female; Glucose; Glucose Tolerance Test; Humans; Injections, Intr | 1974 |
Role of beta-adrenergic receptors in counterregulation to insulin-induced hypoglycemia.
Topics: Animals; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Glucose; Glycerol; Humans; Hypoglyc | 1968 |